Toll Free: 1-888-928-9744
Published: Dec, 2018 | Pages:
105 | Publisher: MAResearch
Industry: Medical Devices | Report Format: Electronic (PDF)
The global Circulating Biomarker for Liquid Biopsy market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. This report provides detailed historical analysis of global market for Circulating Biomarker for Liquid Biopsy from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Circulating Biomarker for Liquid Biopsy market. Leading players of Circulating Biomarker for Liquid Biopsy including: Abbott Laboratories Becton, Dickinson and Company GE Healthcare Epigenomics AG Agilent Technologies Biocept Affymetrix Fluxion Biosciences Market split by Type, can be divided into: Circulating Tumor Cells (CTCs) Circulating Tumor DNA (ctDNA) Cell-Free DNA (cfDNA) Extracellular Vesicles (EVs) Others Market split by Application, can be divided into: Early Cancer Screening Therapy Selection Treatment Monitoring Recurrence Monitoring Orthopedics Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America Brazil, Argentina, Colombia and Chile etc.) Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Contents Chapter 1 Circulating Biomarker for Liquid Biopsy Market Overview 1.1 Circulating Biomarker for Liquid Biopsy Definition 1.2 Global Circulating Biomarker for Liquid Biopsy Market Size Status and Outlook (2013-2028) 1.3 Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Region (2013-2028) 1.4 Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Type (2013-2028) 1.5 Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Application (2013-2028) 1.6 Global Circulating Biomarker for Liquid Biopsy Market Size Comparison by Sales Channel (2013-2028) 1.7 Circulating Biomarker for Liquid Biopsy Market Dynamics 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Circulating Biomarker for Liquid Biopsy Market Segment Analysis by Player 2.1 Global Circulating Biomarker for Liquid Biopsy Sales and Market Share by Player (2016-2018) 2.2 Global Circulating Biomarker for Liquid Biopsy Revenue and Market Share by Player (2016-2018) 2.3 Global Circulating Biomarker for Liquid Biopsy Average Price by Player (2016-2018) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Circulating Biomarker for Liquid Biopsy Market Segment Analysis by Type 3.1 Global Circulating Biomarker for Liquid Biopsy Market by Type 3.1.1 Circulating Tumor Cells (CTCs) 3.1.2 Circulating Tumor DNA (ctDNA) 3.1.3 Cell-Free DNA (cfDNA) 3.1.4 Extracellular Vesicles (EVs) 3.1.5 Others 3.2 Global Circulating Biomarker for Liquid Biopsy Sales and Market Share by Type (2013-2018) 3.3 Global Circulating Biomarker for Liquid Biopsy Revenue and Market Share by Type (2013-2018) 3.4 Global Circulating Biomarker for Liquid Biopsy Average Price by Type (2013-2018) 3.5 Leading Players of Circulating Biomarker for Liquid Biopsy by Type in 2017 3.6 Conclusion of Segment by Type Chapter 4 Circulating Biomarker for Liquid Biopsy Market Segment Analysis by Application 4.1 Global Circulating Biomarker for Liquid Biopsy Market by Application 4.1.1 Early Cancer Screening 4.1.2 Therapy Selection 4.1.3 Treatment Monitoring 4.1.4 Recurrence Monitoring Orthopedics 4.2 Global Circulating Biomarker for Liquid Biopsy Sales and Market Share by Application (2013-2018) 4.3 Leading Consumers of Circulating Biomarker for Liquid Biopsy by Application in 2017 4.4 Conclusion of Segment by Application Chapter 5 Circulating Biomarker for Liquid Biopsy Market Segment Analysis by Sales Channel 5.1 Global Circulating Biomarker for Liquid Biopsy Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Circulating Biomarker for Liquid Biopsy Sales and Market Share by Sales Channel (2013-2018) 5.3 Leading Distributors/Dealers of Circulating Biomarker for Liquid Biopsy by Sales Channel in 2017 5.4 Conclusion of Segment by Sales Channel Chapter 6 Circulating Biomarker for Liquid Biopsy Market Segment Analysis by Region 6.1 Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR by Region (2013-2028) 6.2 Global Circulating Biomarker for Liquid Biopsy Sales and Market Share by Region (2013-2018) 6.3 Global Circulating Biomarker for Liquid Biopsy Revenue and Market Share by Region (2013-2018) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Circulating Biomarker for Liquid Biopsy Market Share by Type 6.4.3 North America Circulating Biomarker for Liquid Biopsy Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Circulating Biomarker for Liquid Biopsy Market Share by Type 6.5.3 Europe Circulating Biomarker for Liquid Biopsy Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Type 6.6.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Circulating Biomarker for Liquid Biopsy Market Share by Type in 2017 6.7.3 South America Circulating Biomarker for Liquid Biopsy Market Share by Application in 2017 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.7.7 Chile 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Type 6.8.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Application 6.8.4 Egypt 6.8.5 Saudi Arabia 6.8.6 South Africa 6.8.7 Nigeria 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Circulating Biomarker for Liquid Biopsy Players 7.1 Abbott Laboratories 7.1.1 Company Snapshot 7.1.2 Product/Business Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 Strategy and SWOT Analysis 7.2 Becton, Dickinson and Company 7.3 GE Healthcare 7.4 Epigenomics AG 7.5 Agilent Technologies 7.6 Biocept 7.7 Affymetrix 7.8 Fluxion Biosciences Chapter 8 Upstream and Downstream Analysis of Circulating Biomarker for Liquid Biopsy 8.1 Industrial Chain of Circulating Biomarker for Liquid Biopsy 8.2 Upstream of Circulating Biomarker for Liquid Biopsy 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Circulating Biomarker for Liquid Biopsy 8.3.1 Leading Distributors/Dealers of Circulating Biomarker for Liquid Biopsy 8.3.2 Leading Consumers of Circulating Biomarker for Liquid Biopsy Chapter 9 Development Trend of Circulating Biomarker for Liquid Biopsy (2018-2028) 9.1 Global Circulating Biomarker for Liquid Biopsy Market Size (Sales and Revenue) Forecast (2018-2028) 9.2 Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Region (2018-2028) 9.3 Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Type (2018-2028) 9.4 Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Application (2018-2028) 9.5 Global Circulating Biomarker for Liquid Biopsy Market Size Forecast by Sales Channel (2018-2028) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification
List of Tables and Figures Figure Circulating Biomarker for Liquid Biopsy Example Figure Global Circulating Biomarker for Liquid Biopsy Revenue (Million $) Status and Outlook (2013-2028) Figure Global Circulating Biomarker for Liquid Biopsy Revenue (Million $) Comparison by Region (2013-2028) Figure Global Circulating Biomarker for Liquid Biopsy Sales Comparison by Type (2013-2028) Figure Global Circulating Biomarker for Liquid Biopsy Sales Comparison by Application (2013-2028) Figure Global Circulating Biomarker for Liquid Biopsy Sales Comparison by Sales Channel (2013-2028) Table Global Circulating Biomarker for Liquid Biopsy Sales by Player (2016-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Player (2016-2018) Figure Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Player in 2017 Table Global Circulating Biomarker for Liquid Biopsy Revenue (Million $) by Player (2016-2018) Table Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Player (2016-2018) Figure Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Player in 2017 Table Global Circulating Biomarker for Liquid Biopsy Average Price by Player (2016-2018) Figure Global Circulating Biomarker for Liquid Biopsy Average Price by Player in 2017 Figure Global Circulating Biomarker for Liquid Biopsy Players Competition Situation - Top 5 Players' Revenue Market Share in 2017 Figure Global Circulating Biomarker for Liquid Biopsy Players Competition Trends - Top 5 Players' Revenue Market Share in 2018 Figure Example of Circulating Tumor Cells (CTCs) Figure Global Circulating Tumor Cells (CTCs) Sales and Growth Rate (2013-2018) Figure Example of Circulating Tumor DNA (ctDNA) Figure Global Circulating Tumor DNA (ctDNA) Sales and Growth Rate (2013-2018) Figure Example of Cell-Free DNA (cfDNA) Figure Global Cell-Free DNA (cfDNA) Sales and Growth Rate (2013-2018) Figure Example of Extracellular Vesicles (EVs) Figure Global Extracellular Vesicles (EVs) Sales and Growth Rate (2013-2018) Figure Example of Others Figure Global Others Sales and Growth Rate (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales by Type (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Type (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Type in 2017 Table Global Circulating Biomarker for Liquid Biopsy Revenue (Million $) by Type (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type in 2017 Table Global Circulating Biomarker for Liquid Biopsy Average Price by Type (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Average Price by Type in 2017 Table Leading Players of Circulating Biomarker for Liquid Biopsy by Type in 2017 Figure Example of Early Cancer Screening Figure Global Circulating Biomarker for Liquid Biopsy for Early Cancer Screening Sales and Growth Rate (2013-2018) Figure Example of Therapy Selection Figure Global Circulating Biomarker for Liquid Biopsy for Therapy Selection Sales and Growth Rate (2013-2018) Figure Example of Treatment Monitoring Figure Global Circulating Biomarker for Liquid Biopsy for Treatment Monitoring Sales and Growth Rate (2013-2018) Figure Example of Recurrence Monitoring Orthopedics Figure Global Circulating Biomarker for Liquid Biopsy for Recurrence Monitoring Orthopedics Sales and Growth Rate (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales by Application (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Application (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Application in 2017 Table Leading Consumers of Circulating Biomarker for Liquid Biopsy by Application in 2017 Figure Example of Direct Channel Figure Global Circulating Biomarker for Liquid Biopsy for Direct Channel Sales and Growth Rate (2013-2018) Figure Example of Distribution Channel Figure Global Circulating Biomarker for Liquid Biopsy for Distribution Channel Sales and Growth Rate (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales by Sales Channel (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Sales Channel (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Sales Channel in 2017 Table Leading Distributors/Dealers of Circulating Biomarker for Liquid Biopsy by Sales Channel in 2017 Table Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR by Region (2013-2028) Table Global Circulating Biomarker for Liquid Biopsy Sales by Region (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Region (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Sales Market Share by Region in 2017 Table Global Circulating Biomarker for Liquid Biopsy Revenue (Million $) by Region (2013-2018) Table Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Region (2013-2018) Figure Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Region in 2017 Table North America Circulating Biomarker for Liquid Biopsy Sales by Country (2013-2018) Figure North America Circulating Biomarker for Liquid Biopsy Sales Market Share by Country (2013-2018) Table North America Circulating Biomarker for Liquid Biopsy Revenue by Country (2013-2018) Figure North America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Country (2013-2018) Figure North America Circulating Biomarker for Liquid Biopsy Sales Market Share by Type in 2017 Figure North America Circulating Biomarker for Liquid Biopsy Sales Market Share by Application in 2017 Figure United States Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure United States Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Canada Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Canada Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Mexico Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Mexico Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Table Europe Circulating Biomarker for Liquid Biopsy Sales by Country (2013-2018) Figure Europe Circulating Biomarker for Liquid Biopsy Sales Market Share by Country (2013-2018) Table Europe Circulating Biomarker for Liquid Biopsy Revenue by Country (2013-2018) Figure Europe Circulating Biomarker for Liquid Biopsy Revenue Market Share by Country (2013-2018) Figure Europe Circulating Biomarker for Liquid Biopsy Sales Market Share by Type in 2017 Figure Europe Circulating Biomarker for Liquid Biopsy Sales Market Share by Application in 2017 Figure Germany Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Germany Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure UK Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure UK Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure France Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure France Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Italy Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Italy Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Russia Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Russia Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Spain Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Spain Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Table Asia-Pacific Circulating Biomarker for Liquid Biopsy Sales by Country (2013-2018) Figure Asia-Pacific Circulating Biomarker for Liquid Biopsy Sales Market Share by Country (2013-2018) Table Asia-Pacific Circulating Biomarker for Liquid Biopsy Revenue by Country (2013-2018) Figure Asia-Pacific Circulating Biomarker for Liquid Biopsy Revenue Market Share by Country (2013-2018) Figure Asia-Pacific Circulating Biomarker for Liquid Biopsy Sales Market Share by Type in 2017 Figure Asia-Pacific Circulating Biomarker for Liquid Biopsy Sales Market Share by Application in 2017 Figure China Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure China Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Japan Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Japan Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Korea Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Korea Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure India Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure India Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Southeast Asia Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Australia Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Australia Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Table South America Circulating Biomarker for Liquid Biopsy Sales by Country (2013-2018) Figure South America Circulating Biomarker for Liquid Biopsy Sales Market Share by Country (2013-2018) Table South America Circulating Biomarker for Liquid Biopsy Revenue by Country (2013-2018) Figure South America Circulating Biomarker for Liquid Biopsy Revenue Market Share by Country (2013-2018) Figure South America Circulating Biomarker for Liquid Biopsy Sales Market Share by Type in 2017 Figure South America Circulating Biomarker for Liquid Biopsy Sales Market Share by Application in 2017 Figure Brazil Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Brazil Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Argentina Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Argentina Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Colombia Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Colombia Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Chile Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Chile Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Table Middle East & Africa Circulating Biomarker for Liquid Biopsy Sales by Country (2013-2018) Figure Middle East & Africa Circulating Biomarker for Liquid Biopsy Sales Market Share by Country (2013-2018) Table Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue by Country (2013-2018) Figure Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue Market Share by Country (2013-2018) Figure Middle East & Africa Circulating Biomarker for Liquid Biopsy Sales Market Share by Type in 2017 Figure Middle East & Africa Circulating Biomarker for Liquid Biopsy Sales Market Share by Application in 2017 Figure Egypt Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Egypt Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Saudi Arabia Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Saudi Arabia Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure South Africa Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure South Africa Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Figure Nigeria Circulating Biomarker for Liquid Biopsy Sales and Growth Rate (2013-2018) Figure Nigeria Circulating Biomarker for Liquid Biopsy Revenue (Million $) and Growth Rate (2013-2018) Table Company Snapshot of Abbott Laboratories Table Circulating Biomarker for Liquid Biopsy Introduction of Abbott Laboratories Table Circulating Biomarker for Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share of Abbott Laboratories (2016-2018) Table Industrial Chain of Circulating Biomarker for Liquid Biopsy Table Manufacturing Cost Structure of Circulating Biomarker for Liquid Biopsy Table General Manufacturing Process of Circulating Biomarker for Liquid Biopsy Table Leading Distributors/Dealers of Circulating Biomarker for Liquid Biopsy Table Leading Consumers of Circulating Biomarker for Liquid Biopsy Figure Global Circulating Biomarker for Liquid Biopsy Sales and Growth Rate Forecast (2018-2028) Figure Global Circulating Biomarker for Liquid Biopsy Revenue and Growth Rate Forecast (2018-2028) Table Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Region (2018-2028) Table Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Type (2018-2028) Table Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Application (2018-2028) Table Global Circulating Biomarker for Liquid Biopsy Market Size and CAGR Forecast by Sales Channel (2018-2028)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.